AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimpee M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Bindlysh Biotec Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimpee M 2mg/500mg Tablet

Diabetace Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetace Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be advised by your doctor.

Primary Ingredients of Glimpee M 2mg/500mg Tablet

The information is unavailable.

Uses of Glimpee M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimpee M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimpee M 2mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimpee M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimpee M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimpee M 2mg/500mg Tablets. Ingest each tablet whole; avoid chewing, crushing, or breaking. Administer this medication with a meal.

How Glimpee M 2mg/500mg Tablet works:

Glimpee M 2mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimpee M 2mg/500mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimpee M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimpee M 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glimpee M 2mg/500mg tablets to individuals with kidney impairment; dosage modification may be necessary. Physician consultation is advised. For patients exhibiting severe kidney disease, the use of Glimpee M 2mg/500mg tablets is contraindicated. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimpee M 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, use is contraindicated in patients experiencing severe hepatic dysfunction.

What if you forget to take Glimpee M 2mg/500mg Tablet :

Should you forget a Glimpee M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimpee M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Glimpee M 2mg/500mg Tablet

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glimpee M 2mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Glimpee M 2mg/500mg Tablet use and seek immediate medical attention.
The Glimpee M 2mg/500mg tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin simultaneously decreases hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glimpee M 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal pain, diarrhea, and headache. Less frequent, but potentially serious, adverse reactions such as lactic acidosis may occur. Prolonged treatment might also result in vitamin B12 deficiency.
Indeed, prolonged use of Glimpee M 2mg/500mg tablets can lead to Vitamin B12 deficiency. This medication impairs the body's ability to absorb Vitamin B12 in the gastrointestinal tract. Left unaddressed, this deficiency can result in anemia, neurological complications, and symptoms such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended by some experts at least annually.
Indeed, Glimpee M 2mg/500mg Tablets may induce hypoglycemia (low blood sugar). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimpee M 2mg/500mg tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol use also elevates the likelihood of lactic acidosis.
Glimpee M 2mg/500mg Table...
47
MRP 58
18% off